Search - tctmd.com

Displaying 701 - 720 of 1245

Sort: Relevancy | Date

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

Podcast TCTMD Talking Points

PORTICO I: A Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

April 17, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Todd Neale

April 03, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

Podcast Heart Sounds

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

Presentation ECHO/IMAGING 2019

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

Presenter: Heidi M. Connolly

March 24, 2019

News Conference News ACC 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Advertisement

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

PORTICO I: A Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Latest Observational Data Support TAVR Durability Through 7 Years

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

TCTMD’s Top 10 Most Popular Stories for March 2019

Top Stories in Cardiology: March 2019

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content